MACH7 TECHNOLOGIES LIMITED — Capital/Financing Update 2017

Sep 21, 2017

ASX Announcement

22 September 2017

==> picture [610 x 89] intentionally omitted <==

Mach7 Wins Prestigious U.S. Academic Medical Centre Account for State-wide Enterprise Imaging

Summary

• Mach7 signs perpetual software licence agreement with University of Vermont Medical Centre

• Agreement makes available the entire suite of Mach7 enterprise imaging solutions to 144 sites across Vermont and Northern New York

• Multi-year agreement, first year deal value US$1.2 million with recurring annual support fees beyond

• UVM designated a Mach7 luminary site

Melbourne, Australia; 22 September 2017: Mach7 Technologies Limited ( Mach7 or the Company ) (ASX: M7T ) announced today it has entered into a perpetual software licence agreement with US Academic Medical Centre, the prestigious University of Vermont Medical Centre (UVM), for its entire suite of enterprise imaging solutions.

Mach7 Enterprise Imaging Platform will serve as the central hub for UVM’s imaging ecosystem enabling the consolidation of all imaging and managing their diverse departmental and enterprise workflows. Mach7’s unique abilities in the areas of intelligent routing and image normalization will empower UVM’s radiologists to read from any location across the state of Vermont with a consistent and informed user experience for optimal patient care.

UVM Medical Centre, the largest employer in Vermont, serves a population of over 1 million with 144 patient care sites, handling at least 600,000 images per year, across Vermont and northern New York. Mach7’s commitment to standards and interoperability was a key factor in their selection so that UVM can leverage their existing information systems and imaging infrastructure including their electronic patient health record. Mach7 is also able to help with UVM’s complex workflows including imaging from their growing use of point-of-care ultrasound imaging. Mike Jackman, CEO commented, “We are very excited about this new strategic partnership with Vermont’s finest heath care system. It demonstrates the power of the Mach7 solutions to improve operational and clinical outcomes, including a partnership to deliver future health care innovations.”

With the licence agreement, UVM will be designated a Mach7 luminary site. The designation underpins the strong partnership between Mach7 and UVM that includes opportunities for UVM to have product development input, additional training, published articles and more. Eric Rice, Mach7 CTO said “We are so pleased to enter into this collaborative relationship with UVM whose reputation is unparalleled. The close proximity of their main campus with our R&D organization, a 10 minute drive, opens the door for many opportunities for us to advance enterprise imaging together.”

==> picture [612 x 123] intentionally omitted <==

ASX Announcement

22 September 2017

==> picture [610 x 89] intentionally omitted <==

About Mach7 Technologies:

Mach7 Technologies (ASX:M7T) develops innovative enterprise imaging IT solutions that create a clear and complete view of the patient to inform diagnosis, reduce care delivery delays and costs, and improve patient outcomes. Mach7’s award-winning enterprise imaging platform provides a vendor neutral foundation for unstructured data consolidation and communication to power interoperability and enables healthcare enterprises to build their best-of-breed clinical ecosystems. Mach7’s sophisticated workflow tools, advanced clinical viewing and optimized vendor neutral archiving solutions unlock silos of legacy systems empowering healthcare providers to own, access and share patient data without boundaries. Visit www.mach7t.com.

Contacts:

Mike Jackman Jenni Pilcher CEO CEO Australia, CFO +1 802-391-8229 (U.S.) +61 3 9646 2222 (Australia) Mike.jackman@mach7t.com jenni.pilcher@mach7t.com

==> picture [612 x 123] intentionally omitted <==